<?xml version="1.0" ?><text author="Aurelio Perez-Favila, Margarita  L Martinez-Fierro, Jessica  G Rodriguez-Lazalde, Miguel  A Cid-Baez, Michelle  de J Zamudio-Osuna, Ma.  del Rosario Martinez-Blanco, Fabiana  E Mollinedo-Montaño, Iram  P Rodriguez-Sanchez, Rodrigo Castañeda-Miranda, Idalia Garza-Veloz" dateCollected="2019-11-03" id="autogum_academic_doc492" shortTile="current-therapeutic" sourceURL="https://www.mdpi.com/1010-660X/55/11/714/htm" speakerCount="0" speakerList="none" title="Current Therapeutic Strategies in Diabetic Foot Ulcers" type="academic">
<head>
<s>
4
.
</s>
<s>
Treatments
for
Diabetic
Foot
Ulcers
</s>
</head>
<p>
<s>
One
strategy
for
the
management
of
patients
with
a
DFU
is
to
introduce
a
multidisciplinary
approach
and
address
the
multifactorial
processes
involved
in
DFUs
.
</s>
<s>
The
use
of
multi-disciplinary
teams
(
MDTs
)
that
include
all
relevant
specialties
(
i.
e.
,
nursing
,
orthopedics
,
plastic
surgery
,
vascular
surgery
,
nutrition
,
and
endocrinology
departments
)
has
shown
an
effect
of
decreasing
the
risks
associated
with
DFUs
and
amputation
by
50
–
85
%
,
lowering
costs
,
and
leading
to
a
better
quality
of
life
for
patients
with
DFUs
.
</s>
</p>
<p>
<s>
Management
of
DFUs
requires
the
correct
classification
of
stage
and
severity
.
</s>
<s>
Adequate
care
for
DFUs
should
include
a
focus
on
DM
control
as
well
as
on
wound
care
,
proper
infection
control
,
relieving
pressure
,
and
optimizing
blood
flow
.
</s>
<s>
The
basic
care
for
the
control
and
treatment
of
DFUs
is
focused
on
the
management
of
adequate
perfusion
,
pressure
mitigation
,
control
of
infection
,
and
debridement
.
</s>
<s>
With
technological
advancement
,
other
series
of
therapies
for
DFUs
have
been
implemented
,
such
as
the
development
of
skin
substitutes
,
negative
pressure
wound
therapy
,
hyperbaric
oxygen
,
the
creation
of
new
wound
dressings
that
include
growth
factors
,
and
the
use
of
tissues
from
bioengineering
.
</s>
<s>
In
this
way
,
treatments
for
DPN
,
PAD
,
and
infections
have
provided
encouraging
results
.
</s>
</p>
<head>
<s>
4.1
.
</s>
<s>
Treatments
for
Diabetic
Peripheral
</s>
<s>
Neuropathy
</s>
</head>
<p>
<s>
DPN
is
a
factor
that
increases
the
risk
of
the
appearance
of
a
DFU
,
owing
to
the
loss
of
sensation
in
the
limb
,
making
patients
vulnerable
to
trauma
.
</s>
<s>
Tight
glycemic
control
is
the
primary
step
and
a
main
feature
of
DPN
management
.
</s>
<s>
Normoglycemia
is
more
effectively
restored
by
a
pancreas
transplant
.
</s>
<s>
Several
studies
have
demonstrated
improvement
of
motor
and
sensory
neuropathy
in
patients
with
DPN
after
they
were
treated
with
a
pancreas
transplant
.
</s>
<s>
However
,
discrepancies
exist
in
the
time
of
response
.
</s>
</p>
<p>
<s>
Pharmacological
treatment
is
used
for
painful
DPN
manifested
as
numbness
,
burning
,
stabbing
,
or
excruciating
or
intractable
pain
;
only
three
treatments
are
approved
by
the
U.S.
Food
and
Drug
Administration
for
the
pain
associated
with
DPN
,
namely
,
pregabalin
,
tapentadol
,
and
duloxetine
.
</s>
</p>
<p>
<s>
Another
pharmacological
therapy
includes
analgesics
,
such
as
tramadol
,
acetaminophen
,
and
some
opioids
such
as
oxycodone
,
which
have
constipation
and
nausea
as
side
effects
,
and
must
be
taken
with
care
because
they
can
be
misused
.
</s>
<s>
Therapy
with
antidepressants
such
as
amitriptyline
,
nortriptyline
,
and
venlafaxine
,
among
others
,
has
shown
an
efficacy
in
neuropathic
pain
management
.
</s>
<s>
It
has
an
effect
on
the
recapture
of
noradrenaline
and
serotonin
,
as
well
as
on
muscarinic
effects
.
</s>
<s>
In
spite
of
this
,
there
are
limited
studies
evaluating
these
drugs
because
their
doses
in
clinical
trials
are
not
entirely
reproducible
in
clinical
practice
.
</s>
</p>
<p>
<s>
Alpha-lipoic
acid
(
ALA
)
has
been
suggested
as
a
potential
therapeutic
agent
in
treating
DPN
;
its
antioxidant
capacity
seems
to
delay
or
reverse
damages
to
peripheral
nerves
.
</s>
<s>
Several
human
randomized
controlled
trials
(
RCTs
)
have
investigated
the
effects
of
ALA
in
the
development
of
diabetic
nephropathy
.
</s>
<s>
A
meta-analysis
of
four
RCTs
(
n
=
653
)
showed
that
,
compared
with
placebo
,
intravenous
ALA
(
600
mg
per
day
)
decreased
symptoms
of
neuropathy
when
administered
for
three
weeks
,
but
symptom
improvement
with
oral
ALA
(
&gt;600
mg
per
day
for
3
–
5
weeks
)
was
not
clinically
significant
.
</s>
<s>
There
is
no
evidence
evaluating
long-term
treatment
.
</s>
</p>
<p>
<s>
Currently
,
treatments
based
on
the
use
of
mesenchymal
stem
cells
(
MSC
)
derived
from
adipose
tissue
have
been
considered
as
a
potential
treatment
against
DPN
.
</s>
<s>
These
therapies
promote
the
production
of
pro-angiogenic
,
neuroprotective
,
and
anti-inflammatory
factors
,
which
have
a
positive
impact
on
the
clinical
manifestations
of
the
disease
.
</s>
</p>
<p>
<s>
On
the
other
hand
,
the
use
of
biological
therapy
with
low
doses
of
IL-6
has
been
demonstrated
to
promote
improvement
of
blood
flow
,
decrease
chronic
inflammation
,
and
regenerate
peripheral
nerve
fibers
.
</s>
<s>
Accordingly
,
IL-6
may
prove
to
be
an
effective
treatment
for
the
protection
and/or
restoration
of
peripheral
nerve
function
in
DPN
;
see
Table
1
.
</s>
</p>
<head>
<s>
4.2
.
</s>
<s>
Treatments
for
Peripheral
Arterial
Disease
(
Ischemia
)
</s>
</head>
<p>
<s>
Ischemia
presenting
in
diabetic
patients
due
to
a
reduction
in
blood
flow
that
occurs
in
both
small
vessels
(
microvascular
,
such
as
capillaries
)
and
large
vessels
(
macrovascular
,
such
as
arteries
and
veins
)
,
or
due
to
a
decrease
of
angiogenesis
,
can
be
treated
through
revascularization
of
at
least
one
of
the
foot
arteries
to
try
to
restore
blood
flow
in
patients
with
a
DFU
whose
toe
pressure
is
&lt;30
mmHg
or
transcutaneous
oxygen
pressure
(
TcPO2
)
&lt;25
mmHg
,
as
well
as
in
those
who
have
a
DFU
that
does
not
heal
with
pressure
on
the
ankle
of
&lt;50
mmHg
or
ankle-brachial
index
(
ABI
)
&lt;0.5
.
</s>
</p>
</text>